Refine your search

  • Books (18)

  • New (18)

to

Custom price range (US$)

to

David H Crean (18 results)

Author: 
Refine with Advanced Search
  • Language: English

    Published by David Crean, 2026

    9798952851153

    • Softcover

    Seller: California Books, Miami, FL, U.S.A.California Books

    5-star seller
    Contact seller

    Condition: New

    US$ 36.00

    US$ 3.00 shipping 
    Ships within U.S.A.

    Quantity: Over 20 available

    Condition: New.

  • Language: English

    Published by David H. Crean, 2026

    9798952851160

    • Hardcover

    Seller: California Books, Miami, FL, U.S.A.California Books

    5-star seller
    Contact seller

    Condition: New

    US$ 42.00

    US$ 3.00 shipping 
    Ships within U.S.A.

    Quantity: Over 20 available

    Condition: New.

  • Language: English

    Published by David H. Crean, 2026

    9798952851153

    • Softcover

    Seller: Home-set, Mannheim, GermanyHome-set

    5-star seller
    Contact seller

    Condition: New

    US$ 81.23

    US$ 54.75 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Softcover/Taschenbuch. Condition: Neu. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." Sprache: Englisch Gewicht in Gramm: 351.…

  • Language: English

    Published by David H. Crean, 2026

    9798952851160

    • Hardcover

    Seller: Home-set, Mannheim, GermanyHome-set

    5-star seller
    Contact seller

    Condition: New

    US$ 90.12

    US$ 54.75 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Gebundene Ausgabe. Condition: Neu. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." Sprache: Englisch Gewicht in Gramm: 412.…

  • Language: English

    Published by David H. Crean, 2026

    9798952851153

    • Softcover
    • Print on Demand

    Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail

    5-star seller
    Contact seller

    Condition: New

    US$ 38.99

     Free Shipping 
    Ships within U.S.A.

    Quantity: 1 available

    Paperback. Condition: new. Paperback. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Language: English

    Published by David H. Crean, 2026

    9798952851153

    • Softcover
    • Print on Demand

    Seller: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US

    5-star seller
    Contact seller

    Condition: New

    US$ 40.35

     Free Shipping 
    Ships within U.S.A.

    Quantity: Over 20 available

    PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Language: English

    Published by David H. Crean, 2026

    9798952851153

    • Softcover
    • Print on Demand

    Seller: PBShop.store UK, Fairford, GLOS, United KingdomPBShop.store UK

    5-star seller
    Contact seller

    Condition: New

    US$ 38.31

    US$ 5.47 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: Over 20 available

    PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Language: English

    Published by David H. Crean, 2026

    9798952851160

    • Hardcover
    • Print on Demand

    Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail

    5-star seller
    Contact seller

    Condition: New

    US$ 44.99

     Free Shipping 
    Ships within U.S.A.

    Quantity: 1 available

    Hardcover. Condition: new. Hardcover. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Language: English

    Published by David H. Crean, 2026

    9798952851160

    • Hardcover
    • Print on Demand

    Seller: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US

    5-star seller
    Contact seller

    Condition: New

    US$ 48.22

     Free Shipping 
    Ships within U.S.A.

    Quantity: Over 20 available

    HRD. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Language: English

    Published by David H. Crean, 2026

    9798952851160

    • Hardcover
    • Print on Demand

    Seller: PBShop.store UK, Fairford, GLOS, United KingdomPBShop.store UK

    5-star seller
    Contact seller

    Condition: New

    US$ 45.38

    US$ 5.47 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: Over 20 available

    HRD. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Language: English

    Published by David H. Crean, 2026

    9798952851153

    • Softcover
    • Print on Demand

    Seller: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller

    5-star seller
    Contact seller

    Condition: New

    US$ 54.45

    US$ 37.00 shipping 
    Ships from Australia to U.S.A.

    Quantity: 1 available

    Paperback. Condition: new. Paperback. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

  • Language: English

    Published by David H. Crean, 2026

    9798952851153

    • Softcover
    • Print on Demand

    Seller: CitiRetail, Stevenage, United KingdomCitiRetail

    5-star seller
    Contact seller

    Condition: New

    US$ 43.32

    US$ 48.64 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: 1 available

    Paperback. Condition: new. Paperback. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

  • Language: English

    Published by David H. Crean, 2026

    9798952851160

    • Hardcover
    • Print on Demand

    Seller: CitiRetail, Stevenage, United KingdomCitiRetail

    5-star seller
    Contact seller

    Condition: New

    US$ 50.76

    US$ 48.64 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: 1 available

    Hardcover. Condition: new. Hardcover. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

  • Language: English

    Published by David H. Crean, 2026

    9798952851160

    • Hardcover
    • Print on Demand

    Seller: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller

    5-star seller
    Contact seller

    Condition: New

    US$ 64.67

    US$ 37.00 shipping 
    Ships from Australia to U.S.A.

    Quantity: 1 available

    Hardcover. Condition: new. Hardcover. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

  • Language: English

    Published by David H. Crean, 2026

    9798952851153

    • Softcover
    • Print on Demand

    Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH

    5-star seller
    Contact seller

    Condition: New

    US$ 64.72

    US$ 38.40 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - What separates the life sciences CEOs who build enduring companies from those who don't In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value.'The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom.'.…

  • Language: English

    Published by David H. Crean, 2026

    9798952851160

    • Hardcover
    • Print on Demand

    Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH

    5-star seller
    Contact seller

    Condition: New

    US$ 66.03

    US$ 38.40 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - What separates the life sciences CEOs who build enduring companies from those who don't In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value.'The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom.'.…

  • Language: English

    Published by David H. Crean, 2026

    9798952851153

    • Softcover
    • Print on Demand

    Seller: preigu, Osnabrück, Germanypreigu

    5-star seller
    Contact seller

    Condition: New

    US$ 73.80

    US$ 76.80 shipping 
    Ships from Germany to U.S.A.

    Quantity: 5 available

    Taschenbuch. Condition: Neu. Dual Fluency | The Language of Science and Capital in Life Sciences | David H. Crean | Taschenbuch | Englisch | 2026 | David H. Crean | EAN 9798952851153 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. …

  • Language: English

    Published by David H. Crean, 2026

    9798952851160

    • Hardcover
    • Print on Demand

    Seller: preigu, Osnabrück, Germanypreigu

    5-star seller
    Contact seller

    Condition: New

    US$ 81.26

    US$ 76.80 shipping 
    Ships from Germany to U.S.A.

    Quantity: 5 available

    Buch. Condition: Neu. Dual Fluency | The Language of Science and Capital in Life Sciences | David H. Crean | Buch | Englisch | 2026 | David H. Crean | EAN 9798952851160 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.…